共查询到20条相似文献,搜索用时 0 毫秒
1.
Jonas Bovijn Leigh Jackson Jenny Censin Chia-Yen Chen Triin Laisk Samantha Laber Teresa Ferreira Sara L. Pulit Craig A. Glastonbury Jordan W. Smoller Jamie W. Harrison Katherine S. Ruth Robin N. Beaumont Samuel E. Jones Jessica Tyrrell Andrew R. Wood Michael N. Weedon Reedik Mägi Michael V. Holmes 《American journal of human genetics》2019,104(1):157-163
2.
Diabetes is the most common and complex metabolic disorder, and one of the most important health threats now. MicroRNAs (miRNAs) are a group of small non-coding RNAs that have been suggested to play a vital role in a variety of physiological processes, including glucose homeostasis. In this study, we investigated the role of miR-185 in diabetes. MiR-185 was significantly downregulated in diabetic patients and mice, and the low level was correlated to blood glucose concentration. Overexpression of miR-185 enhanced insulin secretion of pancreatic β-cells, promoted cell proliferation and protected cells from apoptosis. Further experiments using in silico prediction, luciferase reporter assay and western blot assay demonstrated that miR-185 directly targeted SOCS3 by binding to its 3’-UTR. On the contrary to miR-185’s protective effects, SOCS3 significantly suppressed functions of β-cell and inactivated Stat3 pathway. When treating cells with miR-185 mimics in combination with SOCS3 overexpression plasmid, the inhibitory effects of SOCS3 were reversed. While combined treatment of miR-185 mimics and SOCS3 siRNA induced synergistically promotive effects compared to either miR-185 mimics or SOCS3 siRNA treatment alone. Moreover, we observed that miR-185 level was inversely correlated with SOCS3 expression in diabetes patients. In conclusion, this study revealed a functional and mechanistic link between miR-185 and SOCS3 in the pathogenesis of diabetes. MiR-185 plays an important role in the regulation of insulin secretion and β-cell growth in diabetes. Restoration of miR-185 expression may serve a potentially promising and efficient therapeutic approach for diabetes. 相似文献
3.
2型糖尿病是一种全球性严重危害人类健康的慢性代谢性疾病.在2型糖尿病患者和动物的血液、尿液及受损组织中,糖链的结构均发生了不同程度的变化.本文对近年来有关2型糖尿病发生、发展过程中糖蛋白、蛋白聚糖和糖脂中糖链的结构变化进行综述,为2型糖尿病的诊断及其相关药物的研发提供有用的参考. 相似文献
4.
目的:揭示维药罗补甫克比日丸对糖尿病(DM)性勃起功能障碍(ED)大鼠性激素水平的影响。方法:取50只SD雄性大鼠,从中随机取7只设为正常对照(A)组,余43只行腹腔注射链尿佐菌素(STZ)制造DM动物模型,未成模者为STZ组,成模者用阿朴吗啡(APO)筛选DM性ED模型,并将其随机分为DM性ED对照组、药罗补甫克比日丸(C)组、胰岛素(D)组、联用(E)组,未成ED模者为DM(F)组,共7组。药物干预6周后,检测外周血中性激素水平。结果:正常对照(A)组、DM性ED胰岛素(D)组、DM性ED联用(E)组、STZ(G)组睾酮(T)水平显著高于DM性ED对照(B)组、DM性ED伊木萨克(C)组、DM(F)组,有显著性差异(P0.01);正常对照(A)组、STZ(G)组促黄体生成激素(LH)水平显著低于DM性ED伊木萨克(C)组、DM性ED联用(E)组,有显著性差异(P0.05、P0.01);DM性ED对照(B)组、DM性ED补甫克比日丸(C)组促卵泡刺激素(FSH)水平显著低于DM性ED胰岛素(D)组、DM性ED联用(E)组,有显著性差异(P0.01、P0.05)。结论:维药罗补甫克比日丸可显著改善DM性ED大鼠睾酮水平,且与胰岛素联用优于单用,维药罗补甫克比日丸治疗DM性ED的作用机制可能与T、LH、FSH含量变化有关。 相似文献
5.
6.
W. Silber 《BMJ (Clinical research ed.)》1969,3(5672):688-690
Cineradiographic and manometric studies of oesophageal function were carried out in four different groups of patients (those suspected of having oesophageal disease, with and without symptoms; and in two groups of diabetes, with and without diabetic neuropathy). All groups were found to have abnormal oesophageal function, and this was not commoner in those with diabetic neuropathy. 相似文献
7.
IntroductionStem cell therapy is a novel method for the treatment of diabetic erectile dysfunction (ED). Many relative animal studies have been done to evaluate the efficacy of this therapy in rats.AimsThis meta-analysis was performed to compare the efficacy of different stem cell therapies, to evaluate the influential factors and to determine the optimal stem cell therapeutic strategy for diabetic ED.MethodsWe searched the studies analyzing the efficacy of stem cell therapy for diabetic ED in rats published before September 30, 2015 in PubMed, Web of Science and EBSCO. A random effects meta-analysis was conducted to assess the outcomes of stem cell therapy. Subgroup analysis was also performed by separating these studies based on their different characteristics. Changes in the ratio of intracavernous pressure (ICP) to mean arterial pressure (MAP) and in the structure of the cavernous body were compared.Results10 studies with 302 rats were enrolled in this meta-analysis. Pooled analysis of these studies showed a beneficial effect of stem cell therapy in improving erectile function of diabetic rats (SMD 4.03, 95% CI = 3.22 to 4.84, P< 0.001). In the stem cell therapy group, both the smooth muscle and endothelium content were much more than those in control group. There was also significant increase in the expression of endothelial nitric oxide synthase (eNOS) and neuronal nitric oxide synthase (nNOS), the ratio of smooth muscle to collagen, as well as the secretion of vascular endothelial growth factor (VEGF). Besides, apoptotic cells were reduced by stem cell treatment. The subgroup analysis indicated that modified stem cells were more effective than those without modification.ConclusionsOur results confirmed that stem cell therapy could apparently improve the erectile function of diabetic rats. Some specific modification, especially the gene modification with growth factors, could improve the efficacy of stem cell therapy. Stem cell therapy has potential to be an effective therapeutic strategy for diabetic ED. 相似文献
8.
Constantin Munteanu Mariana Rotariu Marius-Alexandru Turnea Aurelian Anghelescu Irina Albadi Gabriela Dogaru Sînziana Calina Siliteanu Elena Valentina Ionescu Florentina Carmen Firan Anca Mirela Ionescu Carmen Oprea Gelu Onose 《Current issues in molecular biology》2022,44(8):3378
Diabetes mellitus (DM) is a frequent medical problem, affecting more than 4% of the population in most countries. In the context of diabetes, the vascular endothelium can play a crucial pathophysiological role. If a healthy endothelium—which is a dynamic endocrine organ with autocrine and paracrine activity—regulates vascular tone and permeability and assures a proper balance between coagulation and fibrinolysis, and vasodilation and vasoconstriction, then, in contrast, a dysfunctional endothelium has received increasing attention as a potential contributor to the pathogenesis of vascular disease in diabetes. Hyperglycemia is indicated to be the major causative factor in the development of endothelial dysfunction. Furthermore, many shreds of evidence suggest that the progression of insulin resistance in type 2 diabetes is parallel to the advancement of endothelial dysfunction in atherosclerosis. To present the state-of-the-art data regarding endothelial dysfunction in diabetic micro- and macroangiopathy, we constructed this literature review based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). We interrogated five medical databases: Elsevier, PubMed, PMC, PEDro, and ISI Web of Science. 相似文献
9.
10.
11.
12.
抑郁症是一种严重的精神障碍疾病,其发病机制复杂。近年来随着对抑郁症发病机制的深入研究,发现了一些基于非单胺递质的
新型抗抑郁药物分子靶标。综述N -甲基-D-天冬氨酸(NMDA)受体、促肾上腺皮质激素释放因子(CRF)受体、阿片受体、γ-氨基丁
酸B(GABAB) 受体、乙酰胆碱受体等抗抑郁药物作用的新靶标及其相应分子机制研究进展,为开发高效、安全的抗抑郁症新药提供参考。 相似文献
13.
Abhinandan D. Hudwekar Pankul Kotwal Mohd. Ishaq Dar Shilpi Balgotra Ashish Dogra Jaspreet Kour Santosh S. Chobe Utpal Nandi Sajad Hussain Syed Sanghapal D. Sawant 《化学与生物多样性》2023,20(4):e202200707
Continuing research with our earlier finding of sildenafil based analogs in the search of new inhibitors of PDE5 for erectile dysfunction suggested that there is a scope of modifications at N-methylpiperazine ring with hydrophobic region followed by hydrogen bond donor or acceptor region. However, the leads identified earlier had some limitations like poor pharmacokinetic (PK) profile, low aqueous solubility and poor bioavailability. In this direction, a new series of sildenafil based analogs were designed, synthesized and screened for their PDE5 inhibitory activity. In this series compound 18 was found to have excellent in vitro activity with selectivity towards PDE5 isozyme, also the in vivo activity and pharmacokinetic profile was excellent. The cyp inhibition and CaCO2 permeability was also excellent for compound 18 . 相似文献
14.
Rafael Boscolo-Berto Massimo Montisci Silvia Secco Carolina D’Elia Rosella Snenghi Guido Viel Santo Davide Ferrara 《Journal of bioethical inquiry》2016,13(3):439-448
A conflict of interest (COI) is a situation in which a person has competing loyalties or interests that make it difficult to fulfil his or her duties impartially. Conflict of interest is not categorically improper in itself but requires proper management. A SCOPUS literature search was performed for publications on the efficacy/safety of Phospho-Di-Esterase Inhibitors (PDEIs) for treating erectile dysfunction. A categorization tool (CoOpCaT) was used to review and classify the publications as supportive/not-supportive for the discussed active ingredient and reporting or not reporting a COI for that specific drug or for the remaining PDEIs (i.e. competitors). Multivariable binary logistic regression was performed. In the 419 selected records the prevalence of supportive opinions was higher when a COI for the index label was declared. The CoOpCaT showed good internal consistency, discriminative validity and intra/inter-rater agreement. The strongest predictor for a supportive opinion was the total number of financial COIs for the index label. A mild protective effect of the total number of financial COIs for any competitor label was noted. Financial COIs have frequently been associated with bias, and the measures currently adopted to restrain it lack effectiveness. Some evidence for monitoring and/or compensating this bias is reported here, but the ultimate solution remains distant. 相似文献
15.
目的:探讨如何使万艾可更有效治疗老年ED患者.方法:采用回顾性调查研究,分析2004年10月-2007年12月在我院男性健康门诊治老年ED患者143例,按性生活频率分为两组,每月3-4次为实验组共60例,比较两组治疗前平均年龄、并发症及最近10个月的用药量及性生活频率.结果:1.实验组IIEF-5评分由用药前平均6.2分提高到平均20分,对照组由平均5.8分提高到平均18分.2药物起效时间,实验组最短15分钟,最长60分钟,平均30分钟,对照组最短时间20分钟,最长120分钟,平均45分钟(p>0.05).结论:适当增加性生活频率,可减少每次万艾可的用量,并能增加性生活的满意度,使万艾可的治疗效果达到最佳. 相似文献
16.
目的:研究彩色多普勒超声(CDDS)在血管性勃起功能障碍(ED)中的诊断价值,从而为患者临床诊断方式的选择提供参考。方法:选择本院内2012年4月至2015年3月期间因ED入院接受治疗的男性患者248例,在患者接受检查前,需将酚妥拉明、罂粟碱以及前列腺素-E1等药物混合液0.2 m L注入阴茎海绵体内,使得诱导阴茎勃起,随后使用彩色多普勒超声系统进行诊断,对阴茎海绵体动脉的收缩期最大血流率(PSV)、舒张末期血流率(EDV)、阻力指数(RI)等指标进行记录,对各指标诊断ED的应用价值进行评估。结果:在248例患者中,存在血流动力学异常病例172例,其中96例患者为动脉性ED,72例患者为静脉性ED;72例血流动力学正常病例,为非血管性ED。合并糖尿病25例,占10.08%;高血压17例,占6.85%;高血脂116例,占46.77%;阴茎硬结症7例,占2.82%;阴茎海绵体纤维化8例,占3.23;经腹前列腺切除术后者9例,占3.2%,经尿道切除前列腺术后者8例,占3.23;吸烟者196例,占79.03%。血管性ED患者的FPSV、PSV、EDV明显低于非血管性ED患者的,差异均有统计学意义(P0.05);且在血管性ED患者中,动脉性FPSV、ED、EDV患者的PSV明显低于非血管性ED患者的,差异均有统计学意义(P0.05)。在指标对比中,血管性ED患者的RI与非血管性ED患者的RI无明显差异(P0.05),但静脉性ED患者的RI明显低于非血管性ED患者的,差异均有统计学意义(P0.05)。在96例动脉性ED患者中,行选择性阴部内动脉造影术有11例,动脉性病变8例,彩色超声多普勒检查与选择性阴部内动脉造影术符合率为72.73%。结论:在诱导阴茎勃起后,对患者进行彩色多普勒超声系统诊断,能够有效排除阴茎在疲软状态下存在的可变性因素,能够准确反映阴茎血流动力学状态,从而能够准确筛查血管性ED疾病,其检测结果的准确性优于动脉造影,临床应用价值较高,值得进一步推广使用。 相似文献
17.
Yang Chen Xianxiang Xin Haiying Zhang Jianfeng Xu Yong Gao Aihua Tan Xiaobo Yang Xue Qin Yanling Hu Zengnan Mo 《PloS one》2014,9(10)
Erectile dysfunction (ED) is a global disease affecting a large number of people. Some studies have found a relationship between low-grade inflammation and ED. We hypothesized that the immune system might play a key role in the outcome of ED. Five immune agents (C3, C4, IgA, IgM, and IgG) were collected based on the Fangchenggang Area Male Health and Examination Survey (FAMHES), using methods of a traditional cross-sectional analysis. Our results repeated the significant association between ED and metabolic syndrome, obesity, and so forth. However, there seemed to be no positive relation between the tested indexes and ED risk in the baseline analysis (C3: P = 0.737; C4: P = 0.274; IgA: P = 0.943; IgG: P = 0.069; IgM: P = 0.985). Then, after adjusting for age and multivariate covariates, a potentially significant association between ED and IgG was discovered (P = 0.025 and P = 0.034, respectively). Meanwhile, in order to describe the development of ED on a gene level, SNP–set kernel-machine association test (SKAT) was applied with the known humoral immune genes involved. The outcomes suggested that PTAFR (binary P value: 0.0096; continuous P value: 0.00869), IL27 (0.0029; 0.1954), CD37 (0.0248; 0.5196), CD40 (0.7146; 0.0413), IL7R (0.1223; 0.0222), PSMB9 (0.1237; 0.0212), and CXCR3 (0.0849; 0.0478) might be key genes in ED, especially IL27, when we restricted the family-wise error rate (FWER) to 0.5. Our study shows that IgG and seven genes (PTAFR, CD37, CD40, IL7R, PSMB9, CXCR3, and especially IL27) might be key factors in the pathogenesis of ED, which could pave the way for future gene and immune therapies. 相似文献
18.
《Endocrine practice》2020,26(12):1505-1513
Objective: Type 1 diabetes (T1D) is characterized by autoimmune β-cell destruction, but exocrine pancreas abnormalities may also play a role in the disease pathophysiology. Herein, we review the current evidence of exocrine damage in T1D and discuss its underlying pathophysiology, clinical evaluation, and treatment.Method: Extensive literature search was performed for “type 1 diabetes” and “exocrine dysfunction” on PubMed and Google Scholar databases.Results: T1D pancreata are significantly smaller than controls, both in weight and volume. T cells, dendritic cells, neutrophils, and products of complement activation are seen in T1D exocrine tissues. Exocrine pancreas fibrosis, arteriosclerosis, fatty infiltration, and acinar atrophy are also observed on histology. Pancreatic exocrine insufficiency (PEI) can be assessed through direct exocrine testing, fecal elastase concentration, and measurement of serum exocrine enzymes. The prevalence of PEI in T1D varies by modality and study but is consistently greater than controls. The clinical relevance of PEI in T1D is debatable, as many patients with laboratory evidence of PEI are asymptomatic. However, in PEI-symptomatic patients reported benefits of pancreatic enzyme replacement therapy (PERT) include relief of gastrointestinal symptoms, improved quality of life, better glycemic control, and optimal nutrition.Conclusion: Exocrine pancreas abnormalities often occur in T1D. Whether exocrine dysfunction occurs simultaneously with β-cell destruction, as a result of β-cell loss, or as a combination of both remains to be definitively answered. In T1D with gastrointestinal complaints, PEI should be evaluated, usually via fecal elastase measurements. PERT is recommended for T1D patients with symptoms and laboratory evidence of PEI.Abbreviations: AAb+ = autoantibody positive; AAb- = autoantibody negative; FEC = fecal elastase concentration; PEI = pancreatic exocrine insufficiency; PERT = pancreatic enzyme replacement therapy; PP = pancreatic polypep-tide; T1D = type 1 diabetes 相似文献
20.
《Journal of receptor and signal transduction research》2013,33(5):671-776
AbstractThe cloning of a great number of receptors and channels has revealed that many of these targets for drug discovery can be grouped into superfamilies based on sequence and structural similarities. This review presents an overview of how molecular biological approaches have revealed a plethora of receptor subtypes, led to new definitions of subtypes and isoforms, and played a role in the development of highly selective drugs. Moreover, the diversity of subtypes has molded current views of the structure and function of receptor families. Practical difficulties and limitations inherent in the characterization of the ligand binding and signaling properties of expressed recombinant receptors are discussed. The importance of evaluating drug-receptor interactions that differ with temporally transient and distinct receptor conformational states is emphasized. Structural motifs and signal transduction features are presented for the following major receptor superfamilies: ligand-gated ion channel, voltage-dependent ion channel, G-protein coupled, receptor tyrosine-kinase, receptor protein tyrosine-phosphatase, cytokine and nuclear hormone. In addition, a prototypic receptor is analyzed to illustrate functional properties of a given family. The review concludes with a discussion of future directions in receptor research that will impact drug discovery, with a specific focus on orphan receptors as targets for drug discovery. Methods for classifying orphan receptors based upon homologies with members of existing superfamilies are presented together with molecular approaches to the greater challenge of defining their physiological roles. Besides revealing new orphan receptors, the human genome sequencing project will result in the identification of an abundance of novel receptors that will be molecular targets for the development of highly selective drugs. These findings will spur the discovery and development of an exciting new generation of receptor-subtype specific drugs with enhanced therapeutic specificity. 相似文献